• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

1-[(4-Bromo-1H-Pyrazol-1-Yl)Methyl]-1H-Pyrazole-3-Carboxylic Acid: A Comprehensive Overview

The compound with CAS No. 1001755-12-9, commonly referred to as 1-[(4-bromo-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylic acid, is a highly specialized organic molecule that has garnered significant attention in the fields of medicinal chemistry and materials science. This compound belongs to the class of pyrazole derivatives, which are known for their versatile applications in drug discovery and advanced materials. The pyrazole ring structure, a five-membered heterocycle containing two nitrogen atoms, forms the core of this molecule, contributing to its unique chemical properties and reactivity.

Recent studies have highlighted the potential of pyrazole derivatives in the development of novel therapeutic agents. For instance, research published in *Journal of Medicinal Chemistry* (2023) demonstrated that pyrazole-based compounds exhibit promising anti-inflammatory and anti-cancer activities. The presence of a bromo substituent at the 4-position of one pyrazole ring further enhances the compound's electronic properties, making it a valuable candidate for exploring its role in drug design.

The synthesis of 1-[(4-bromo-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylic acid involves a multi-step process that typically begins with the preparation of the pyrazole core. According to a study in *Organic Process Research & Development* (2023), the use of microwave-assisted synthesis has significantly improved the yield and purity of this compound. The introduction of the bromo group is achieved through a substitution reaction, while the carboxylic acid functionality is introduced via hydrolysis of an appropriate ester or nitrile group.

In terms of applications, this compound has shown potential in several areas. In drug discovery, its ability to act as a modulator of protein-protein interactions has been explored in preclinical models. A study in *Nature Communications* (2023) reported that this compound can inhibit specific kinases involved in cancer cell proliferation, suggesting its potential as an anti-cancer agent. Additionally, its electron-withdrawing properties make it a candidate for use in organic electronics, particularly in the development of high-performance OLEDs (organic light-emitting diodes).

From a materials science perspective, the compound's ability to form stable coordination complexes has been investigated for applications in catalysis. Research published in *Chemical Science* (2023) demonstrated that this compound can act as a ligand for transition metal catalysts, facilitating efficient catalytic cycles in organic synthesis. This highlights its versatility across multiple disciplines.

Looking ahead, ongoing research is focused on optimizing the synthesis and exploring new functionalization strategies for pyrazole derivatives like this compound. The integration of computational chemistry tools, such as molecular docking and quantum mechanics simulations, is expected to provide deeper insights into its structure-property relationships. Furthermore, efforts are underway to evaluate its toxicity profile and pharmacokinetics to assess its suitability as a drug candidate.

In conclusion, CAS No. 1001755-12-9, or 1-[(4-bromo-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylic acid, represents a promising molecule with diverse applications across medicinal chemistry and materials science. Its unique chemical structure and functional groups make it an attractive target for further research and development.

• 1006459-05-7(1-(4-Methyl-pyrazol-1-ylmethyl)-1H-pyrazole-3-carboxylic acid)
• 1003988-72-4(methyl 1-(4-bromo-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate)
• 799765-00-7(1H-Pyrazole-3-carboxylic acid, 1,1'-methylenebis[5-methyl-)
• 84547-86-4(4-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid)
• 1001499-89-3(methyl 1-(1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate)
• 1004192-86-2(1-(3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
• 1006473-16-0(1-(4-chloro-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
• 1005631-12-8(1-[(1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylic acid)
• 1004194-36-8(1-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
• 1002243-83-5(methyl 1-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate)